The New Jersey CDISC User’s Group is resuming its activities. As a starting point, we plan to focus on CDISC implementation challenges and experience, for both legacy data and new studies, as well as knowledge sharing across companies.
Our next meeting will be held the afternoon of Monday, June 17, at Novartis Pharmaceuticals Corporation in East Hanover. Tele/web-conferencing will also be available.
Please contact Susan Lenczyk (susan.lenczyk@novartis.com) by Wednesday, June 12, to register for this meeting.
If you would also like to present a paper at the meeting, please contact Gina Wood (georgina.wood@novartis.com) by Friday, May 17. Topics of interest include (but are not limited to):
- CDISC submission experiences: FDA feedback, lessons learned, validation approach
Pinnacle 21 uses cookies to make our site easier for you to use. By continuing to use this website, you agree to our use of cookies. For more info visit our Privacy Policy.
The New Jersey CDISC User’s Group is resuming its activities. As a starting point, we plan to focus on CDISC implementation challenges and experience, for both legacy data and new studies, as well as knowledge sharing across companies.
Our next meeting will be held the afternoon of Monday, June 17, at Novartis Pharmaceuticals Corporation in East Hanover. Tele/web-conferencing will also be available.
Please contact Susan Lenczyk (susan.lenczyk@novartis.com) by Wednesday, June 12, to register for this meeting.
If you would also like to present a paper at the meeting, please contact Gina Wood (georgina.wood@novartis.com) by Friday, May 17. Topics of interest include (but are not limited to):
- CDISC submission experiences: FDA feedback, lessons learned, validation approach
- Conversion of legacy data
We look forward to seeing you at the meeting!